PART 1: Advancing Digital Health Technologies (DHTs) for CNS Clinical Trials
PART 1: Advancing Digital Health Technologies (DHTs) for CNS Clinical Trials
11 PagesThis white paper examines how digital health technologies can improve measurement in central nervous system clinical trials. Traditional clinician-reported outcomes may lack sensitivity, introduce rater variability, and increase trial complexity and cost. Digital tools such as actigraphy sensors, cognitive testing, speech analysis, smartphone applications, geolocation data, video analysis, and connected devices can capture frequent, passive, real-world information about patient function. These measures may improve precision, reveal changes missed by conventional assessments, reduce patient burden, and support smaller or faster trials.
